SCHEMBL174383

SCHEMBL174383

CC(C)(C)c1cc2nc(C(F)(F)c3ccc(F)cc3)nc(Nc3cc[nH]n3)c2s1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175189 0.85 NTRK1 (0.32) —
SCHEMBL166022 0.85 NTRK1 (0.43) —
SCHEMBL175046 0.81 PAK4 (0.33) PRKCI
SCHEMBL174490 0.79 AURKB (0.41) —
SCHEMBL174933 0.79 AURKA (0.40) PRKCI
SCHEMBL173922 0.79 JAK2 (0.47) PRKCI
SCHEMBL174171 0.78 NTRK1 (0.41) —
SCHEMBL174445 0.77 CCNE2 (0.44) —
SCHEMBL174795 0.77 FLT3 (0.36) —
SCHEMBL173271 0.76 AURKB (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 — — EP disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 — — WO disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 — — WO disclosed
Send feedback